Sterling Investment Advisors Ltd. Boosts Position in Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS)

Sterling Investment Advisors Ltd. lifted its holdings in Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) by 3.7% in the 3rd quarter, Holdings Channel.com reports. The fund owned 158,695 shares of the company’s stock after buying an additional 5,605 shares during the quarter. Tema Cardiovascular and Metabolics ETF comprises approximately 1.4% of Sterling Investment Advisors Ltd.’s portfolio, making the stock its 23rd largest holding. Sterling Investment Advisors Ltd. owned 0.06% of Tema Cardiovascular and Metabolics ETF worth $5,332,000 at the end of the most recent quarter.

Tema Cardiovascular and Metabolics ETF Stock Performance

Shares of NASDAQ:HRTS traded down $0.06 during mid-day trading on Friday, hitting $33.34. 11,352 shares of the company traded hands, compared to its average volume of 24,392. The firm has a market cap of $82.68 million, a P/E ratio of 32.89 and a beta of 0.93. Tema Cardiovascular and Metabolics ETF has a 52-week low of $26.26 and a 52-week high of $36.03. The firm’s 50 day simple moving average is $34.19 and its 200 day simple moving average is $33.34.

About Tema Cardiovascular and Metabolics ETF

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.